Research output per year
Research output per year
Personal profile
Overview
Professor of Adult Psychiatry, University of Manchester 1994-current
Director, Institute of Brain, Behaviour and Mental Health 2012-2016
Honorary Consultant in Psychiatry, Manchester Mental Health and Social Care Trust
Associate Director, NIHR Mental Health Research Network 2004-2015
NIHR Senior Investigator and Senior Leader 2008-2016. Emeritus NIHR SI 2016.
Member, Executive Greater Manchester CLRN 2009-2015
Academic Lead, Mental Health Domain, Manchester Academic HS Centre 2013-current
Trustee and Board Member, Rethink Mental Illness 2009-12
Biography
Shôn Lewis has been Professor of Adult Psychiatry at the University of Manchester since 1994. He trained clinically at the Maudsley Hospital. He has been Chair of the Royal College
of Psychiatrists’ research committee and served on the Wellcome Trust and the MRC Neurosciences and Mental Health Boards.
His research interests focus on risk factors and new interventions in schizophrenia and psychosis, including the use of new technologies. He has published 5 books and 180 scientific articles, including 3 citation classics. He receives research funding from MRC, NIHR and EU. He was elected in 2008 as a fellow of the Academy of Medical Sciences. He has held an NIHR Senior Investigator award since 2008.
He works as an honorary consultant psychiatrist in Manchester Mental Health and Social Care Trust and was R&D Director 2004-8. He was a trustee and board member of the charity Rethink Mental Illness 2009-12 and was involved in setting up the Schizophrenia Commission. He is Associate Director of the NIHR CRN Mental Health and Neuroscience Division and is Director of the Institute of Brain, Behaviour and Mental Health at the University of Manchester.
Research interests
Shôn Lewis's research interests focus on risk factors and new interventions in schizophrenia and psychosis, including the use of new technologies. He has published 5 books and 180 scientific articles, including 3 citation classics. He receives research funding from MRC, NIHR and EU.
Qualifications
BSc Psychol (1st Class)
MBBS
MRCPsych
MPhil
MD
F Med Sci
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research Beacons, Institutes and Platforms
- Digital Futures
- Christabel Pankhurst Institute
Fingerprint
Dive into the research topics where Shon Lewis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Acceptability of reducing sedentariness using a mobile-phone application based on ‘if then’ plans for people with psychosis: a focus-group study conducted in the North West of the UK
Bailey, R., Bartlett, K., Hassan, L., Armitage, C. J., Stockton-Powdrell, C., Machin, M., Lewis, S. & Epton, T., 29 Apr 2022, (Accepted/In press) In: The International journal of social psychiatry.Research output: Contribution to journal › Article › peer-review
-
EMPOWER: A feasibility cluster randomised controlled trial of a blended digital intervention for relapse prevention in schizophrenia
Ainsworth, J., Bucci, S., Lewis, S., Machin, M., Yung, A. R. & et al., 16 Mar 2022, (Accepted/In press) In: The Lancet Psychiatry.Research output: Contribution to journal › Article › peer-review
-
Adaptive Symptom Monitoring using Hidden Markov — an Application in Ecological Momentary Assessment
Hulme, W. J., Martin, G. P., Sperrin, M., Casson, A. J., Bucci, S., Lewis, S. & Peek, N., 1 May 2021, In: IEEE Journal of Biomedical and Health Informatics. 25, 5, p. 1770-1780 11 p., 9226077.Research output: Contribution to journal › Article › peer-review
Open AccessFile236 Downloads (Pure) -
Deconstructing depression and negative symptoms of schizophrenia; differential and longitudinal immune correlates, and response to minocycline treatment
Krynicki, C. R., Dazzan, P., Pariante, C. M., Barnes, N. M., Vincent, R. C., Roberts, A., Giordano, A., Watson, A., Suckling, J., Barnes, T. R. E., Husain, N., Jones, P. B., Joyce, E., Lawrie, S. M., Lewis, S., Deakin, B. & Upthegrove, R., Jan 2021, In: Journal of Public Health Medicine. 91, p. 498-504 7 p.Research output: Contribution to journal › Article › peer-review
-
Dopamine and Glutamate in Antipsychotic-Responsive Compared with Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA)
Egerton, A., Murphy, A., Donocik, J., Anton, A., Barker, G. J., Collier, T., Deakin, B., Drake, R., Eliasson, E., Emsley, R., Gregory, C. J., Griffiths, K., Kapur, S., Kassoumeri, L., Knight, L., Lambe, E. J. B., Lawrie, S. M., Lees, J., Lewis, S., Lythgoe, D. J., & 14 others, 1 Mar 2021, In: Schizophrenia Bulletin. 47, 2, p. 505-516 12 p.Research output: Contribution to journal › Article › peer-review
Open Access
-
NIHR Manchester Biomedical Research Centre
Bruce, I., Lord, G., Lennon, R., Black, G., Wedge, D., Morris, A., Hussell, T., Sharrocks, A., Stivaros, S., Buch, M., Gough, J., Kostarelos, K., Thistlethwaite, F., Kadler, K., Barton, A., Hyrich, K., Mcbeth, J., O'Neill, T., Vestbo, J., Simpson, A., Singh, S., Smith, J., Felton, T., Murray, C., Griffiths, C., Cullum, N., Rhodes, L., Warren, R., Paus, R., Dumville, J., Viros Usandizaga, A., Keavney, B., Tomaszewski, M., Allan, S., Body, R., Cartwright, E., Heagerty, A., Kalra, P., Miller, C., Rutter, M., Smith, C., Trafford, A., Evans, D., Crosbie, E., Crosbie, P., Harvie, M., Howell, S., Renehan, A., Dive, C., Blackhall, F., Landers, D., Krebs, M., Cook, N., Clarke, R., Taylor, S., Jorgensen, C., Lorigan, P., Jayson, G., Valle, J., Mccabe, M., Armstrong, A., Freitas, A., Illidge, T., Choudhury, A., Hoskin, P., West, C., Van Herk, M., Faivre-Finn, C., Bristow, R., Kirkby, K., Birtle, A., Mackay, R., Radford, J., Linton, K., Higham, C., Munro, K., Plack, C., Arden Armitage, C., Bruce, I., Moore, D., Saunders, G., Stone, M., Haddock, G., Lewis, S., Elliott, R., Green, J., Lovell, K., Morrison, A., Shaw, J., Bucci, S., Ainsworth, J., Webb, R., Newman, W., Banka, S., Clayton-Smith, J., Payne, K., Moldovan, R., Wynn, R. & Jones, S.
1/12/22 → 30/11/27
Project: Research
-
Active Assistance for Psychological Therapy 2.0 (Actissist 2.0): Digital Intervention for Co-Producing Care in Psychosis.
Bucci, S., Ainsworth, J., Berry, K., Edge, D., Haddock, G., Lewis, S. & Machin, M.
1/10/17 → 30/09/20
Project: Research
-
Enhancing the credibility, usefulness and relevance of patient experience data in services for people with long term physical and mental health conditions using digital data capture and improved analysis of narrative data.
Sanders, C., Ainsworth, J., Boaden, R., Bower, P., Daker-White, G., Davies, L., Dixon, W., Hodgson, D., Kontopantelis, E., Lewis, S., Lovell, K. & Nenadic, G.
1/04/16 → 31/03/18
Project: Research
-
Active Assistance for Psychological Therapy (Actissist): Software to Improve Access and Adherance to CBT Targeting Key Relapse Indicators in Psychosis.
Bucci, S., Ainsworth, J., Barrowclough, C., Berry, K., Buchan, I., Edge, D., Emsley, R., Haddock, G. & Lewis, S.
2/09/13 → 30/06/16
Project: Research
Impacts
-
CBTPsychosis: Transforming psychological healthcare delivery for people with schizophrenia
Gillian Haddock (Participant), Christine Barrowclough (Participant), Anthony Morrison (Participant), Richard Bentall (Participant), Nicholas Tarrier (Participant), Shon Lewis (Participant), Linda Davies (Participant), Graham Dunn (Participant) & Sara Tai (Participant)
Impact: Health impacts, Societal impacts, Economic impacts
-
CUtLASS: Changing attitudes and prescribing practice: cost effectiveness of first versus second generation antipsychotic drugs in people with schizophrenia
Shon Lewis (Participant), Graham Dunn (Participant) & Linda Davies (Participant)
Impact: Health impacts, Economic impacts
-
ReduceDUP: Socio-economic impact of reducing the duration of untreated psychosis
Matthew Marshall (Participant), Shon Lewis (Participant), Richard Drake (Participant), Austin Lockwood (Participant), Shahid Akhtar (Participant) & Clifford Haley (Participant)
Impact: Health impacts, Societal impacts
-
World’s first effective treatment to prevent psychosis has been implemented as standard treatment in NHS mental health services across England
Anthony Morrison (Participant), Paul French (Participant), Richard Bentall (Participant), Linda Davies (Participant), Graham Dunn (Participant), Shon Lewis (Participant), Sophie Parker (Participant) & Rory Byrne (Participant)
Impact: Health and wellbeing
Press/Media
-
THE GUARDIAN: How technology is transforming mental health treatment
15/05/19
1 Media contribution
Press/Media: Research